Close Menu

Expert insights from UArizona Health Sciences

Kenneth S. Ramos, MD, PhD, PharmB, served as associate vice president for precision health sciences at the University of Arizona Health Sciences, director of the Center for Applied Genetics and Genomic Medicine and the MD-PhD Program, and professor of medicine. In 2019, Dr. Ramos accepted a position as executive director of the Institute of Biosciences and Technology in Houston and assistant vice chancellor for Health Services at The Texas A&M University System.

Dr. Ramos is a physician-scientist with interests in molecular and precision medicine, particularly as it relates to vascular pathology, oncology and chronic diseases of the lung. His translational research program integrates diverse approaches ranging from molecular genetics to population-based studies to elucidate genetic and genomic mechanisms of pathogenesis, and to develop novel approaches and therapies to minimize chronic diseases caused by environmental injury. Ongoing translational studies in his laboratory focus on the study of repetitive genetic elements in the mammalian genome and their role in genome plasticity, toxicity and disease, while clinical studies focus on the development and characterization of diagnostic and prognostic biomarkers of cancer and chronic pulmonary disease to advance the goals of personalized genomic medicine.  He has directed two NIH P30 Centers of Excellence working at the interface between genomics and environmental health and medicine and have provided administrative and scientific leadership for two academic centers focusing on genetics and genomic medicine. He has influenced the career of many scientists through my involvement in several NIH-funded training and career development programs where he has mentored over 100 doctoral, medical, veterinary, undergraduate and high school students, many of whom have gone on to successful careers in academia, medicine, government and industry. He is deeply committed to initiatives that advance precision medicine and its applications to reduce disease burden and health disparities, improve quality of healthcare and reduce costs.

Recent Posts

Valerie Schaibley, PhD
Kenneth S. Ramos, MD, PhD, PharmB
As physicians begin to order an increasing number of genetic tests, a question remains: who can help patients, and sometimes providers, interpret genetic information?
Valerie Schaibley, PhD
Kenneth S. Ramos, MD, PhD, PharmB
In 2013, Academy Award-winning actress Angelina Jolie wrote a now famous opinion piece for the New York Times detailing her journey involving genetic testing for breast and ovarian cancer.
Valerie Schaibley, PhD
Kenneth S. Ramos, MD, PhD, PharmB
Coccidioidomycosis, or “cocci” for short, is the medical term for Valley fever, an infectious disease that affects thousands of people in Arizona every year.
Valerie Schaibley, PhD
Kenneth S. Ramos, MD, PhD, PharmB
Noninvasive prenatal testing (NIPT), one of the newest additions in genomic testing, is a simple blood test that can tell a lot about a baby’s likelihood of having certain genetic conditions.
Valerie Schaibley, PhD
Kenneth S. Ramos, MD, PhD, PharmB
Do I really want to know? This is one of the most important questions people ask themselves before genetic testing. And this conundrum is more relevant for conditions like Alzheimer’s disease.
Valerie Schaibley, PhD
Kenneth S. Ramos, MD, PhD, PharmB
Most commonly, asthma manifests itself as having difficulty breathing, accompanied by any number of other symptoms, including, chest pain or tightness, anxiety, fast heart rate, cough, throat irritation and/or wheezing.
Valerie Schaibley, PhD
Kenneth S. Ramos, MD, PhD, PharmB
There is power in numbers. When a researcher is studying the causes of a human disease, the more people involved in the study, the greater the probability that the study will generate useful results.
Valerie Schaibley, PhD
Kenneth S. Ramos, MD, PhD, PharmB
Epilepsy is the fourth most-common neurological disorder in adults, and the most common neurological condition in children. About 1 in 26 people will develop epilepsy over the course of their lifetime.
Valerie Schaibley, PhD
Kenneth S. Ramos, MD, PhD, PharmB
Almost every medication we take comes with some side effects. Thankfully, most of these risks are small and the side effects for common medications are mild.